These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 32706072)
1. Stathmin 1 promotes the progression of liver cancer through interacting with YAP1. Liu YP; Pan LL; Kong CC Eur Rev Med Pharmacol Sci; 2020 Jul; 24(13):7335-7344. PubMed ID: 32706072 [TBL] [Abstract][Full Text] [Related]
3. Induction of Chromosome Instability by Activation of Yes-Associated Protein and Forkhead Box M1 in Liver Cancer. Weiler SME; Pinna F; Wolf T; Lutz T; Geldiyev A; Sticht C; Knaub M; Thomann S; Bissinger M; Wan S; Rössler S; Becker D; Gretz N; Lang H; Bergmann F; Ustiyan V; Kalin TV; Singer S; Lee JS; Marquardt JU; Schirmacher P; Kalinichenko VV; Breuhahn K Gastroenterology; 2017 Jun; 152(8):2037-2051.e22. PubMed ID: 28249813 [TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA muskelin 1 antisense RNA (MKLN1-AS) is a potential diagnostic and prognostic biomarker and therapeutic target for hepatocellular carcinoma. Guo C; Zhou S; Yi W; Yang P; Li O; Liu J; Peng C Exp Mol Pathol; 2021 Jun; 120():104638. PubMed ID: 33878313 [TBL] [Abstract][Full Text] [Related]
5. Overexpression of Rac GTPase Activating Protein 1 Contributes to Proliferation of Cancer Cells by Reducing Hippo Signaling to Promote Cytokinesis. Yang XM; Cao XY; He P; Li J; Feng MX; Zhang YL; Zhang XL; Wang YH; Yang Q; Zhu L; Nie HZ; Jiang SH; Tian GA; Zhang XX; Liu Q; Ji J; Zhu X; Xia Q; Zhang ZG Gastroenterology; 2018 Oct; 155(4):1233-1249.e22. PubMed ID: 30009820 [TBL] [Abstract][Full Text] [Related]
6. The oncoprotein HBXIP up-regulates YAP through activation of transcription factor c-Myb to promote growth of liver cancer. Wang Y; Fang R; Cui M; Zhang W; Bai X; Wang H; Liu B; Zhang X; Ye L Cancer Lett; 2017 Jan; 385():234-242. PubMed ID: 27765671 [TBL] [Abstract][Full Text] [Related]
7. STMN1 upregulation mediates hepatocellular carcinoma and hepatic stellate cell crosstalk to aggravate cancer by triggering the MET pathway. Zhang R; Gao X; Zuo J; Hu B; Yang J; Zhao J; Chen J Cancer Sci; 2020 Feb; 111(2):406-417. PubMed ID: 31785057 [TBL] [Abstract][Full Text] [Related]
8. c-Src promotes the growth and tumorigenesis of hepatocellular carcinoma via the Hippo signaling pathway. Yang J; Zhang X; Liu L; Yang X; Qian Q; Du B Life Sci; 2021 Jan; 264():118711. PubMed ID: 33186566 [TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA PICSAR knockdown inhibits the progression of cutaneous squamous cell carcinoma by regulating miR-125b/YAP1 axis. Lu X; Gan Q; Gan C; Zheng Y; Cai B; Li X; Li D; Yin G Life Sci; 2021 Jun; 274():118303. PubMed ID: 32841663 [TBL] [Abstract][Full Text] [Related]
10. Activation of β-catenin and Yap1 in human hepatoblastoma and induction of hepatocarcinogenesis in mice. Tao J; Calvisi DF; Ranganathan S; Cigliano A; Zhou L; Singh S; Jiang L; Fan B; Terracciano L; Armeanu-Ebinger S; Ribback S; Dombrowski F; Evert M; Chen X; Monga SPS Gastroenterology; 2014 Sep; 147(3):690-701. PubMed ID: 24837480 [TBL] [Abstract][Full Text] [Related]
11. Thyroid hormone suppresses expression of stathmin and associated tumor growth in hepatocellular carcinoma. Tseng YH; Huang YH; Lin TK; Wu SM; Chi HC; Tsai CY; Tsai MM; Lin YH; Chang WC; Chang YT; Chen WJ; Lin KH Sci Rep; 2016 Dec; 6():38756. PubMed ID: 27934948 [TBL] [Abstract][Full Text] [Related]
12. Evodiamine inhibits proliferation and promotes apoptosis of hepatocellular carcinoma cells via the Hippo-Yes-Associated Protein signaling pathway. Zhao S; Xu K; Jiang R; Li DY; Guo XX; Zhou P; Tang JF; Li LS; Zeng D; Hu L; Ran JH; Li J; Chen DL Life Sci; 2020 Jun; 251():117424. PubMed ID: 32057900 [TBL] [Abstract][Full Text] [Related]
13. Anti-STMN1 therapy improves sensitivity to antimicrotubule drugs in esophageal squamous cell carcinoma. Wang S; Akhtar J; Wang Z Tumour Biol; 2015 Sep; 36(10):7797-806. PubMed ID: 25944168 [TBL] [Abstract][Full Text] [Related]
14. Decursin inhibits the growth of HepG2 hepatocellular carcinoma cells via Hippo/YAP signaling pathway. Li J; Wang H; Wang L; Tan R; Zhu M; Zhong X; Zhang Y; Chen B; Wang L Phytother Res; 2018 Dec; 32(12):2456-2465. PubMed ID: 30251417 [TBL] [Abstract][Full Text] [Related]
15. Stathmin1 overexpression associated with polyploidy, tumor-cell invasion, early recurrence, and poor prognosis in human hepatoma. Hsieh SY; Huang SF; Yu MC; Yeh TS; Chen TC; Lin YJ; Chang CJ; Sung CM; Lee YL; Hsu CY Mol Carcinog; 2010 May; 49(5):476-87. PubMed ID: 20232364 [TBL] [Abstract][Full Text] [Related]
16. Aberrantly high activation of a FoxM1-STMN1 axis contributes to progression and tumorigenesis in FoxM1-driven cancers. Liu J; Li J; Wang K; Liu H; Sun J; Zhao X; Yu Y; Qiao Y; Wu Y; Zhang X; Zhang R; Yang A Signal Transduct Target Ther; 2021 Feb; 6(1):42. PubMed ID: 33526768 [TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor α-induced protein 1 as a novel tumor suppressor through selective downregulation of CSNK2B blocks nuclear factor-κB activation in hepatocellular carcinoma. Xiao Y; Huang S; Qiu F; Ding X; Sun Y; Wei C; Hu X; Wei K; Long S; Xie L; Xun Y; Chen W; Zhang Z; Liu N; Xiang S EBioMedicine; 2020 Jan; 51():102603. PubMed ID: 31901862 [TBL] [Abstract][Full Text] [Related]
18. miR-199a-3p inhibits cell proliferation and induces apoptosis by targeting YAP1, suppressing Jagged1-Notch signaling in human hepatocellular carcinoma. Ren K; Li T; Zhang W; Ren J; Li Z; Wu G J Biomed Sci; 2016 Nov; 23(1):79. PubMed ID: 27832779 [TBL] [Abstract][Full Text] [Related]
19. COPB2 promotes cell proliferation and tumorigenesis through up-regulating YAP1 expression in lung adenocarcinoma cells. Pu X; Wang J; Li W; Fan W; Wang L; Mao Y; Yang S; Liu S; Xu J; Lv Z; Xu L; Shu Y Biomed Pharmacother; 2018 Jul; 103():373-380. PubMed ID: 29674272 [TBL] [Abstract][Full Text] [Related]
20. Role of miR-193a-5p in the proliferation and apoptosis of hepatocellular carcinoma. Wang JT; Wang ZH Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7233-7239. PubMed ID: 30468466 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]